Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionDividends Paid - CommonFree Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activities
Growth Metrics
Income Statement
Others
Ratios

Selectis Health (GBCS) Free Cash Flow (2017 - 2025)

Historic Free Cash Flow for Selectis Health (GBCS) over the last 14 years, with Q3 2025 value amounting to $275795.0.

  • Selectis Health's Free Cash Flow rose 12247.69% to $275795.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $417875.0, marking a year-over-year increase of 11272.67%. This contributed to the annual value of -$1.9 million for FY2024, which is 46706.32% down from last year.
  • Per Selectis Health's latest filing, its Free Cash Flow stood at $275795.0 for Q3 2025, which was up 12247.69% from -$240894.0 recorded in Q2 2025.
  • Selectis Health's 5-year Free Cash Flow high stood at $2.4 million for Q3 2023, and its period low was -$1.9 million during Q4 2023.
  • In the last 5 years, Selectis Health's Free Cash Flow had a median value of -$195241.0 in 2021 and averaged -$95820.1.
  • Within the past 5 years, the most significant YoY rise in Selectis Health's Free Cash Flow was 85575.54% (2021), while the steepest drop was 92281.11% (2021).
  • Over the past 5 years, Selectis Health's Free Cash Flow (Quarter) stood at $1.3 million in 2021, then plummeted by 65.3% to $453908.0 in 2022, then tumbled by 508.92% to -$1.9 million in 2023, then skyrocketed by 76.66% to -$433197.0 in 2024, then surged by 163.67% to $275795.0 in 2025.
  • Its last three reported values are $275795.0 in Q3 2025, -$240894.0 for Q2 2025, and $816171.0 during Q1 2025.